🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Giving chemotherapy before a peripheral stem cell transplant sto...
Status
Completed
Location
Multiple Locations
Start Date
2001-01
Trial ID
NCT00550784
RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2013-06
Trial ID
NCT01886976
Treatments Being Tested
To study the 5-year immunogenicity against a quadrivalent HPV vaccine in pa...
Status
Completed
Location
Department of Medicine, Tuen Mun Hospital
Start Date
2015-07
Trial ID
NCT02477254
Treatments Being Tested
The purpose of this trial is to study the diagnostic role of skin test in i...
Status
Completed
Location
Faculty of Medicine, Chulalongkorn University
Start Date
2008-11
Trial ID
NCT00819494
Treatments Being Tested
This study will enroll individuals who have: * Completed primary series of...
Status
Completed
Location
University of California, San Diego
Start Date
2021-12-06
Trial ID
NCT05077254
Colorectal cancer (CRC) is a global burden and one of the most frequent typ...
Status
Completed
Location
Hospital Universitario La Fe
Start Date
2018-05-04
Trial ID
NCT03601351
Treatments Being Tested
This study will follow 40 healthy, vaginally delivered infants that are pri...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2015-01
Trial ID
NCT02568579
Treatments Being Tested
The immune system may be involved in the recognition and destruction of tum...
Status
Recruiting
Location
University Hospital of Besançon
Start Date
2025-02-10
Trial ID
NCT06626269
Treatments Being Tested
The purpose of this study is to assess the efficacy of two doses of subling...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00674700
RATIONALE: Aurora A kinase inhibitor MLN8237 may stop the growth of tumor c...
Status
Terminated
Location
Vanderbilt-Ingram Cancer Center
Start Date
2011-10
Trial ID
NCT01316692